Found: 20
Select item for more details and to access through your institution.
Population analysis of the pharmacokinetics and the haematological toxicity of the fluorouracil-epirubicin-cyclophosphamide regimen in breast cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 143, doi. 10.1007/s00280-005-0140-2
- By:
- Publication type:
- Article
A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 157, doi. 10.1007/s00280-005-0152-y
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 173, doi. 10.1007/s00280-005-0149-6
- By:
- Publication type:
- Article
Potassium oxonate, an enzyme inhibitor compounded in S-1, reduces the suppression of antitumor immunity induced by 5-fluorouracil.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 183, doi. 10.1007/s00280-005-0150-0
- By:
- Publication type:
- Article
Phase-I study of a new schedule based on increasing days of topotecan administration associated with dose individualisation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 189, doi. 10.1007/s00280-005-0142-0
- By:
- Publication type:
- Article
Antiproliferative and Antiproteolytic activity of Pentoxifylline in cultures of B16F10 Melanoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 195, doi. 10.1007/s00280-005-0155-8
- By:
- Publication type:
- Article
Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 203, doi. 10.1007/s00280-005-0157-6
- By:
- Publication type:
- Article
Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 210, doi. 10.1007/s00280-005-0147-8
- By:
- Publication type:
- Article
The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 219, doi. 10.1007/s00280-005-0158-5
- By:
- Publication type:
- Article
Folate receptor specific anti-tumor activity of folate–mitomycin conjugates.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 229, doi. 10.1007/s00280-005-0151-z
- By:
- Publication type:
- Article
Gemcitabine aerosol: in vitro antitumor activity and deposition imaging for preclinical safety assessment in baboons.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Preferential extravasation and accumulation of liposomal vincristine in tumor comparing to normal tissue enhances antitumor activity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 245, doi. 10.1007/s00280-005-0145-x
- By:
- Publication type:
- Article
Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 256, doi. 10.1007/s00280-005-0148-7
- By:
- Publication type:
- Article
Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 266, doi. 10.1007/s00280-005-0143-z
- By:
- Publication type:
- Article
Toxic death-case after capecitabine + oxaliplatin (XELOX) administration: probable implication of dihydropyrimidine deshydrogenase deficiency.
- Published in:
- 2006
- By:
- Publication type:
- journal article
5-Fluorouracil can cross brain–blood barrier and cause encephalopathy: should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 276, doi. 10.1007/s00280-005-0159-4
- By:
- Publication type:
- Article
Molecular targets of cancer chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 279, doi. 10.1007/s00280-005-0170-9
- By:
- Publication type:
- Article
Angiotensin 1–7 and risk for breast cancer recurrence.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Reply to letter to the editors (K Altundag et al.).
- Published in:
- 2006
- By:
- Publication type:
- Letter